Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 29/11/2020
SIETES contiene 93175 citas

 
 
 1 a 20 de 52 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita originalTiene citas relacionadas Cita con resumen
Jakobsen JC, Nielsen EE, Feinberg J, Katakam KK, Fobian K, Hauser G, Poropat G, Djurisic S, Weiss KH, Bjelakovic M, Bjelakovic G, Klingenberg SL, Liu JP, Nikolova D, Koretz RL, Gluud C. Direct-acting antivirals for chronic hepatitis C. Cochrane Database of Systematic Reviews 2017;6:6 de junio. [Ref.ID 101674]
3.Enlace a cita original
Dworzynski K, Pollit V, Kelsey A, Higgins B, Palmer K, on behalf of the Guideline Development Group. Management of acute upper gastrointestinal bleeding: summary of NICE guidance. BMJ 2012;344:45-7. [Ref.ID 93219]
5.
Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med 2010;362:823-32. [Ref.ID 87959]
7.Tiene citas relacionadas Cita con resumen
Palmer K, Naim M, on behalf of the Guideline Development Group. Management of acute gastrointestinal blood loss: summary of SIGN guidelines. BMJ 2008;337:928-30. [Ref.ID 84269]
8.
González R, Zamora J, Gómez-Camarero J, Molinero L-M, Bañares R, Albillos A. Meta-analysis: combination endoscopic and drug therapy to prevent variceal rebleeding in cirrhosis. Ann Intern Med 2008;149:109-22. [Ref.ID 83601]
9.Tiene citas relacionadas Cita con resumen
Quigley EMM, Fried M, Krabshuis JH. Use of evidence in WHO recommendations. Lancet 2007;370:824. [Ref.ID 81008]
10.Tiene citas relacionadas
Mukherjee S, Sorrell MF. Beta-blockers to prevent esophageal varices - an unfulfilled promise. N Engl J Med 2005;353:2288-90. [Ref.ID 75561]
11.Tiene citas relacionadas Cita con resumen
Groszman RJ, García-Tsao G, Bosch J, Grace ND, Burroughs AK, Planas R, Escorsell A, García-Pagan JC, Patch D, Matloff DS, Gao H, Makuch R, for the Portal Hypertension Collaborative Group. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med 2005;353:2254-61. [Ref.ID 75558]
12.
Cenci C, Del Favero A. Cirrosi epatica: l'approccio terapeutico. Informazioni sui Farmaci 2005;29:97-102. [Ref.ID 75019]
13.
Dallal HJ, Palmer KR. Upper gastrointestinal haemorrhage. BMJ 2001;323:1115-7. [Ref.ID 59453]
14.
Krige JEJ, Beckingham IJ. Portal hypertension - I: varices. BMJ 2001;322:348-51. [Ref.ID 55131]
15. Cita con resumen
Calès P, Masliah C, Bernard B, Garnier PP, Silvain C, Szostak-Talbodec N, Bronowicki J-P, Ribard D, Botta-Fridlund D, Hillon P, Besseghir K, Lebrec D, for the French Club for the Study of Portal Hypertension. Early administration of vapreotide for variceal bleeding in patients with cirrhosis. N Engl J Med 2001;344:23-8. [Ref.ID 54917]
16. Cita con resumen
Anónimo. Early management of bleeding oesophageal varices. Drug Ther Bull 2000;38:37-40. [Ref.ID 50750]
17.Tiene citas relacionadas
Burroughs AK, Patch D. Primary prevention of bleeding from esophageal varices. N Engl J Med 1999;340:1033-5. [Ref.ID 44012]
18.Tiene citas relacionadas Cita con resumen
Sarin SK, Lamba GS, Kumar M, Misra A, Murthy NS. Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. N Engl J Med 1999;340:988-93. [Ref.ID 44009]
19.
McCormack G, McCormick PA. A practical guide to the management of oesophageal varices. Drugs 1999;57:327-35. [Ref.ID 43824]
20. Cita con resumen
Anónimo. Octréotide et varices oesophagiennes - rien de nouveau pour les hémorragies. Prescrire 1999;19:264-6. [Ref.ID 43712]
Seleccionar todas
 
 1 a 20 de 52 siguiente >>